THE IMPACT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY ON RENAL-TRANSPLANTATION

被引：0

作者：

ETTENGER, RB ^{[1
]}

MARIK, J ^{[1
]}

GRIMM, P ^{[1
]}

机构：

[1] UNIV CALIF LOS ANGELES,SCH MED,DIV PEDIAT NEPHROL,LOS ANGELES,CA 90024

来源：

AMERICAN JOURNAL OF KIDNEY DISEASES | 1991年 / 18卷 / 04期

关键词：

RENAL TRANSPLANTATION; RECOMBINANT HUMAN ERYTHROPOIETIN;

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：57 / 61

页数：5

共 19 条

[1]

BRAUN WE, 1989, 15TH ANN AM SOC HIST

[2]

Cecka J M, 1988, Clin Transpl, P365

[3]

CHEIGH JS, 1981, JAMA-J AM MED ASSOC, V246, P135

[4]

DEIERHOI MH, 1989, TRANSPLANT P, V21, P771

[5] ANEMIA LESSENS AND ITS PREVENTION WITH RECOMBINANT HUMAN ERYTHROPOIETIN WORSENS GLOMERULAR INJURY AND HYPERTENSION IN RATS WITH REDUCED RENAL MASS [J].

GARCIA, DL ;

ANDERSON, S ;

RENNKE, HG ;

BRENNER, BM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (16) :6142-6146

[6] EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON HLA SENSITIZATION AND CELL-MEDIATED-IMMUNITY [J].

GRIMM, PC ;

SINAITRIEMAN, L ;

SEKIYA, NM ;

ROBERTSON, LS ;

ROBINSON, BJ ;

FINE, RN ;

ETTENGER, RB .

KIDNEY INTERNATIONAL, 1990, 38 (01) :12-18

[7]

JONES AR, 1976, LANCET, V1, P529

[8]

KEOWN PA, 1990, SEMIN NEPHROL, V10, P52

[9] IMPROVED ALLOGRAFT SURVIVAL OF STRONG IMMUNE RESPONDER HIGH-RISK RECIPIENTS WITH ADJUVANT ANTI-THYMOCYTE GLOBULIN THERAPY [J].

KERMAN, RH ;

FLOYD, M ;

VANBUREN, CT ;

KAHAN, BD .

TRANSPLANTATION, 1980, 30 (06) :450-454

[10] ERYTHROPOIETIN THERAPY AND THE ANTIBODY-LEVELS OF HIGHLY SENSITIZED PATIENTS AWAITING KIDNEY-TRANSPLANTATION [J].

KOSKIMIES, S ;

LAUTENSCHLAGER, I ;

GRONHAGENRISKA, C ;

HAYRY, P .

TRANSPLANTATION, 1990, 50 (04) :707-709

← 1 2 →